Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study - 11/02/19
and the
Ustekinumab–Crohn's Disease–Neutrophilic Dermatosis Study Group
Funding sources: None. |
|
Disclosure: Dr Guégan was supported by Janssen for national and international congress attendance. Dr Beaugerie has received consulting fees, lecture fees, and research support from Janssen. Dr Amiot has received lecture fees and travel accommodation from Janssen. Dr Risi-Pugliese, Dr Seksik, Dr Bouaziz, Dr Chasset, Dr Moguelet, Dr Gornet, Dr Bourrier, and Dr Francès have no conflicts of interest to disclose. |
Vol 80 - N° 3
P. 781-784 - mars 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?